JPWO2021028336A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021028336A5
JPWO2021028336A5 JP2022507725A JP2022507725A JPWO2021028336A5 JP WO2021028336 A5 JPWO2021028336 A5 JP WO2021028336A5 JP 2022507725 A JP2022507725 A JP 2022507725A JP 2022507725 A JP2022507725 A JP 2022507725A JP WO2021028336 A5 JPWO2021028336 A5 JP WO2021028336A5
Authority
JP
Japan
Prior art keywords
pyran
triazol
methyl
thio
tetrahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022507725A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543666A5 (https=
JP2022543666A (ja
JP7612662B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072238 external-priority patent/WO2021028336A1/en
Publication of JP2022543666A publication Critical patent/JP2022543666A/ja
Publication of JP2022543666A5 publication Critical patent/JP2022543666A5/ja
Publication of JPWO2021028336A5 publication Critical patent/JPWO2021028336A5/ja
Application granted granted Critical
Publication of JP7612662B2 publication Critical patent/JP7612662B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022507725A 2019-08-09 2020-08-07 (ヘテロ)アリール-メチル-チオ-ベータ-d-ガラクトピラノシド誘導体 Active JP7612662B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EPPCT/EP2019/071416 2019-08-09
EP2019071416 2019-08-09
PCT/EP2020/072238 WO2021028336A1 (en) 2019-08-09 2020-08-07 (hetero)aryl-methyl-thio-beta-d-galactopyranoside derivatives

Publications (4)

Publication Number Publication Date
JP2022543666A JP2022543666A (ja) 2022-10-13
JP2022543666A5 JP2022543666A5 (https=) 2023-08-15
JPWO2021028336A5 true JPWO2021028336A5 (https=) 2023-08-15
JP7612662B2 JP7612662B2 (ja) 2025-01-14

Family

ID=71948599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507725A Active JP7612662B2 (ja) 2019-08-09 2020-08-07 (ヘテロ)アリール-メチル-チオ-ベータ-d-ガラクトピラノシド誘導体

Country Status (9)

Country Link
US (1) US12404295B2 (https=)
EP (1) EP4010076B1 (https=)
JP (1) JP7612662B2 (https=)
KR (1) KR102854071B1 (https=)
CN (1) CN114206893A (https=)
CA (1) CA3147082A1 (https=)
ES (1) ES2972509T3 (https=)
TW (1) TWI873165B (https=)
WO (1) WO2021028336A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4010348B1 (en) 2019-08-09 2023-12-20 Idorsia Pharmaceuticals Ltd (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
JP7604457B2 (ja) 2019-08-15 2024-12-23 イドルシア・ファーマシューティカルズ・リミテッド 2-ヒドロキシシクロアルカン-1-カルバモイル誘導体
CA3148365A1 (en) 2019-08-29 2021-03-04 Martin Bolli Alpha-d-galactopyranoside derivatives
ES3014851T3 (en) 2020-10-06 2025-04-25 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
KR20230104190A (ko) 2020-11-02 2023-07-07 이도르시아 파마슈티컬스 리미티드 갈렉틴-3 억제 2-히드록시시클로알칸-1-카르바모일 유도체
KR20230145111A (ko) 2021-02-09 2023-10-17 이도르시아 파마슈티컬스 리미티드 히드록시헤테로시클로알칸-카르바모일 유도체
PL4301748T3 (pl) 2021-03-03 2025-09-08 Idorsia Pharmaceuticals Ltd Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu
WO2022189459A2 (en) * 2021-03-10 2022-09-15 Galecto Biotech Ab Novel galactoside inhibitor of galectins

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100172D0 (sv) 2001-01-22 2001-01-22 Ulf Nilsson New inhibitors against galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
JP2015535233A (ja) 2012-10-31 2015-12-10 ガレクト・バイオテック・エイビイ ガレクチン−3のガラクトシド阻害剤及び肺線維症のためのその使用
WO2014078655A1 (en) 2012-11-15 2014-05-22 Tufts University Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
JP6904906B2 (ja) 2015-01-30 2021-07-21 ガレクト・バイオテック・エイビイ ガレクチンの新規なガラクトシド阻害剤
KR101974793B1 (ko) 2015-07-06 2019-05-02 길리애드 사이언시즈, 인코포레이티드 Cot 조정제 및 그의 사용 방법
JP7086008B2 (ja) * 2016-03-04 2022-06-17 ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニー ガレクチンに関連する疾患を予防および処置するためのセレノガラクトシド化合物およびその使用
CA3025867A1 (en) 2016-07-12 2018-01-18 Galecto Biotech Ab Alpha-d-galactoside inhibitors of galectins
CA3062648A1 (en) 2017-05-12 2018-11-15 Galectin Sciences, Llc Compounds for the prevention and treatment of diseases and the use thereof
US20200061095A1 (en) 2017-05-12 2020-02-27 Galectin Sciences, Llc Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof
WO2019067702A1 (en) 2017-09-27 2019-04-04 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
WO2019075045A1 (en) 2017-10-11 2019-04-18 Bristol-Myers Squibb Company INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3
AU2018361991A1 (en) 2017-10-31 2020-05-14 Galectin Sciences, Llc Selenogalactoside compounds for the treatment of systemic insulin resistance disorders and the use thereof
JP2022508719A (ja) 2018-10-15 2022-01-19 ガレクト バイオテック エービー ガレクチンのガラクトシド阻害剤のプロドラッグ
CN113366007A (zh) 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
JP7486484B2 (ja) 2018-11-21 2024-05-17 ガレクト バイオテック エービー ガレクチンのα-D-ガラクトシド阻害剤
EP3953349A1 (en) 2019-04-10 2022-02-16 Bristol-Myers Squibb Company Small molecule inhibitors of galectin-3
CA3141436A1 (en) 2019-07-03 2021-01-07 Fredrik Zetterberg Novel galactoside inhibitor of galectins
CN114450282A (zh) 2019-07-05 2022-05-06 格莱克特生物技术公司 半乳糖凝集素的新型半乳糖苷抑制剂
EP4010348B1 (en) 2019-08-09 2023-12-20 Idorsia Pharmaceuticals Ltd (2-acetamidyl)thio-beta-d-galactopyranoside derivatives
JP7604457B2 (ja) 2019-08-15 2024-12-23 イドルシア・ファーマシューティカルズ・リミテッド 2-ヒドロキシシクロアルカン-1-カルバモイル誘導体
CA3148365A1 (en) 2019-08-29 2021-03-04 Martin Bolli Alpha-d-galactopyranoside derivatives
ES3014851T3 (en) 2020-10-06 2025-04-25 Idorsia Pharmaceuticals Ltd Spiro derivatives of alpha-d-galactopyranosides
KR20230104190A (ko) 2020-11-02 2023-07-07 이도르시아 파마슈티컬스 리미티드 갈렉틴-3 억제 2-히드록시시클로알칸-1-카르바모일 유도체
KR20230145111A (ko) 2021-02-09 2023-10-17 이도르시아 파마슈티컬스 리미티드 히드록시헤테로시클로알칸-카르바모일 유도체
PL4301748T3 (pl) 2021-03-03 2025-09-08 Idorsia Pharmaceuticals Ltd Triazolilo-metylo podstawione pochodne alfa-d-galaktopiranozydu

Similar Documents

Publication Publication Date Title
US8507512B2 (en) Soluble guanylate cyclase activators
JP2865872B2 (ja) 3−(5−テトラゾリル−ベンジル)アミノ−ピペリジン誘導体およびタキキニンのアンタゴニスト
JP2025016684A5 (https=)
AU2009245715B2 (en) Trisubstituted pyrazoles as acetylcholine receptor modulators
CN106170288B (zh) 药物化合物
US9840477B2 (en) Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents
TWI802591B (zh) 具有環狀構造的化合物
WO2020103817A1 (zh) TGF-βR1抑制剂及其应用
TW201639829A (zh) 經取代磺醯胺化合物
JPH10508824A (ja) タキキニンアンタゴニストとしてのベンゾフラン誘導体
CZ20022931A3 (cs) Azetidinové deriváty, jejich příprava a farmaceutické prostředky, které je obsahují
US7060836B2 (en) Lactams as tachykinin antagonists
JP2025505645A (ja) Apol1の阻害剤としてのスピロピペリジン誘導体およびその使用方法
CN114206893A (zh) (杂)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
TWI454461B (zh) 作為nk3拮抗劑之異喹啉酮衍生物
JP2006522779A (ja) 4−置換キノリン誘導体、その調製方法、中間体及び医薬組成物
JPWO2021028336A5 (https=)
US7232833B2 (en) 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
TW200821303A (en) Organic compounds
JP5677457B2 (ja) ピロリジン誘導体
JPWO2021028570A5 (https=)
JPWO2021028323A5 (https=)
KR101304130B1 (ko) Nk3 수용체 길항제로서 피롤리딘 유도체
KR101764458B1 (ko) 치환 피리딘 화합물
DK2841426T3 (en) ANTIBACTERIAL QUINOLIN DERIVATIVES